"Nuvaring resubmit this quarter"
you know they are shit when they say something and do another, late last year, they mentioned they will resubmit the nuvaring application by end 2020. well they haven't yet and this looks like a 2022 if they are ever to be approved at all. by then all the pharma have their generic myring available.
yeah strong AUD became an excuse...
Ann: 2021 Half Year Investor Presentation, page-2
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.37 |
Change
0.360(5.14%) |
Mkt cap ! $626.9M | |||
| Open | High | Low | Value | Volume |
| $7.01 | $7.46 | $6.99 | $2.670M | 366.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $7.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.39 | 959 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.34 |
Change
0.360 ( 4.83 %) |
||||
| Open | High | Low | Volume | ||
| $7.00 | $7.47 | $7.00 | 48349 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MYX (ASX) Chart |